Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10

Literature DB >> 33229354

Niveditha Devasenapathy¹, Zhikang Ye², Mark Loeb², Fang Fang², Borna Tadayon Najafabadi², Yingqi Xiao², Rachel Couban², Philippe Bégin², Gordon Guyatt².

Abstract

Entities: Chemical

Mesh：

Year: 2020 PMID： 33229354 PMCID： PMC7721266 DOI： 10.1503/cmaj.200642-f

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

32 in total

1. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.

Authors: Sabue Mulangu; Lori E Dodd; Richard T Davey; Olivier Tshiani Mbaya; Michael Proschan; Daniel Mukadi; Mariano Lusakibanza Manzo; Didier Nzolo; Antoine Tshomba Oloma; Augustin Ibanda; Rosine Ali; Sinaré Coulibaly; Adam C Levine; Rebecca Grais; Janet Diaz; H Clifford Lane; Jean-Jacques Muyembe-Tamfum; Billy Sivahera; Modet Camara; Richard Kojan; Robert Walker; Bonnie Dighero-Kemp; Huyen Cao; Philippe Mukumbayi; Placide Mbala-Kingebeni; Steve Ahuka; Sarah Albert; Tyler Bonnett; Ian Crozier; Michael Duvenhage; Calvin Proffitt; Marc Teitelbaum; Thomas Moench; Jamila Aboulhab; Kevin Barrett; Kelly Cahill; Katherine Cone; Risa Eckes; Lisa Hensley; Betsey Herpin; Elizabeth Higgs; Julie Ledgerwood; Jerome Pierson; Mary Smolskis; Ydrissa Sow; John Tierney; Sumathi Sivapalasingam; Wendy Holman; Nikki Gettinger; David Vallée; Jacqueline Nordwall
Journal: N Engl J Med Date: 2019-11-27 Impact factor: 91.245

2. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

Authors: Andre C Kalil
Journal: JAMA Date: 2020-03-24 Impact factor: 56.272

3. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline.

Authors: Zhikang Ye; Bram Rochwerg; Ying Wang; Neill K Adhikari; Srinivas Murthy; François Lamontagne; Robert A Fowler; Haibo Qiu; Li Wei; Ling Sang; Mark Loeb; Ning Shen; Minhua Huang; Zhaonan Jiang; Yaseen M Arabi; Luis Enrique Colunga-Lozano; Li Jiang; Younsuck Koh; Dong Liu; Fang Liu; Jason Phua; Aizong Shen; Tianyi Huo; Bin Du; Suodi Zhai; Gordon H Guyatt
Journal: CMAJ Date: 2020-04-29 Impact factor: 8.262

4. Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

Authors: Ivan F N Hung; Kelvin K W To; Cheuk-Kwong Lee; Kar-Lung Lee; Wing-Wa Yan; Kenny Chan; Wai-Ming Chan; Chun-Wai Ngai; Kin-Ip Law; Fu-Loi Chow; Raymond Liu; Kang-Yiu Lai; Candy C Y Lau; Shao-Haei Liu; Kwok-Hung Chan; Che-Kit Lin; Kwok-Yung Yuen
Journal: Chest Date: 2013-08 Impact factor: 9.410

5. Efficacy of convalescent plasma for the treatment of severe influenza.

Authors: Zhiheng Xu; Jianmeng Zhou; Yongbo Huang; Xuesong Liu; Yonghao Xu; Sibei Chen; Dongdong Liu; Zhimin Lin; Xiaoqing Liu; Yimin Li
Journal: Crit Care Date: 2020-07-29 Impact factor: 9.097

6. Use of convalescent plasma therapy in SARS patients in Hong Kong.

Authors: Y Cheng; R Wong; Y O Y Soo; W S Wong; C K Lee; M H L Ng; P Chan; K C Wong; C B Leung; G Cheng
Journal: Eur J Clin Microbiol Infect Dis Date: 2005-01 Impact factor: 3.267

Review 7. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

Authors: John Mair-Jenkins; Maria Saavedra-Campos; J Kenneth Baillie; Paul Cleary; Fu-Meng Khaw; Wei Shen Lim; Sophia Makki; Kevin D Rooney; Jonathan S Nguyen-Van-Tam; Charles R Beck
Journal: J Infect Dis Date: 2014-07-16 Impact factor: 5.226

8. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

Authors: Y O Y Soo; Y Cheng; R Wong; D S Hui; C K Lee; K K S Tsang; M H L Ng; P Chan; G Cheng; J J Y Sung
Journal: Clin Microbiol Infect Date: 2004-07 Impact factor: 8.067

9. Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Authors: Bin Zhang; Shuyi Liu; Tan Tan; Wenhui Huang; Yuhao Dong; Luyan Chen; Qiuying Chen; Lu Zhang; Qingyang Zhong; Xiaoping Zhang; Yujian Zou; Shuixing Zhang
Journal: Chest Date: 2020-03-31 Impact factor: 9.410

10. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors: Zunyou Wu; Jennifer M McGoogan
Journal: JAMA Date: 2020-04-07 Impact factor: 56.272

1 in total

1. Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis.

Authors: Roberto Ariel Abeldaño Zuñiga; Ruth Ana María González-Villoria; María Vanesa Elizondo; Anel Yaneli Nicolás Osorio; David Gómez Martínez; Silvia Mercedes Coca
Journal: Ther Adv Respir Dis Date: 2021 Jan-Dec Impact factor: 4.031

1 in total